Teal Health为林业发展局审查的家庭宫颈癌筛查装置筹集了1 000万澳元,以提高筛查率。 Teal Health raises $10M for FDA-reviewed at-home cervical cancer screening device to boost screening rates.

妇女保健公司Teal Health获得了另外1 000万美元的资金,共计2 300万美元,用于开发其家庭宫颈癌筛查装置Teal WandTM,正在接受林业发展局的审查。 Women's health company Teal Health has secured an additional $10 million in funding, totaling $23 million, to develop its at-home cervical cancer screening device, the Teal Wand™, which is under FDA review. 该公司旨在通过解决不舒适和获得传统考试机会有限的问题,提高筛查率和改善健康成果。 The company aims to increase screening rates and improve health outcomes by addressing discomfort and limited access to traditional exams. 投资者包括爱默生集体和先驱投资者。 Investors include Emerson Collective and Forerunner.